BRPI0519705A2 - composiÇÕes, proteÍnas de fusço e mÉtodos de estimular uma resposta imune em um indivÍduo - Google Patents
composiÇÕes, proteÍnas de fusço e mÉtodos de estimular uma resposta imune em um indivÍduoInfo
- Publication number
- BRPI0519705A2 BRPI0519705A2 BRPI0519705-8A BRPI0519705A BRPI0519705A2 BR PI0519705 A2 BRPI0519705 A2 BR PI0519705A2 BR PI0519705 A BRPI0519705 A BR PI0519705A BR PI0519705 A2 BRPI0519705 A2 BR PI0519705A2
- Authority
- BR
- Brazil
- Prior art keywords
- compositions
- fusion proteins
- individual
- immune response
- stimulating
- Prior art date
Links
- 102000037865 fusion proteins Human genes 0.000 title abstract 4
- 108020001507 fusion proteins Proteins 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 4
- 230000028993 immune response Effects 0.000 title abstract 3
- 230000004936 stimulating effect Effects 0.000 title abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 102000018697 Membrane Proteins Human genes 0.000 abstract 1
- 108010052285 Membrane Proteins Proteins 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 206010022000 influenza Diseases 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6075—Viral proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6093—Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63825404P | 2004-12-21 | 2004-12-21 | |
| US63835004P | 2004-12-21 | 2004-12-21 | |
| US64506705P | 2005-01-19 | 2005-01-19 | |
| US65320705P | 2005-02-15 | 2005-02-15 | |
| US66687805P | 2005-03-31 | 2005-03-31 | |
| US68207705P | 2005-05-18 | 2005-05-18 | |
| US74120205P | 2005-11-30 | 2005-11-30 | |
| PCT/US2005/046662 WO2006069262A2 (en) | 2004-12-21 | 2005-12-21 | Compositions of influenza viral proteins and methods of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0519705A2 true BRPI0519705A2 (pt) | 2009-03-10 |
Family
ID=36272492
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0519705-8A BRPI0519705A2 (pt) | 2004-12-21 | 2005-12-21 | composiÇÕes, proteÍnas de fusço e mÉtodos de estimular uma resposta imune em um indivÍduo |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1831259A2 (enExample) |
| JP (1) | JP2008524261A (enExample) |
| AU (2) | AU2005319141B8 (enExample) |
| BR (1) | BRPI0519705A2 (enExample) |
| CA (1) | CA2593746A1 (enExample) |
| MX (1) | MX2007007586A (enExample) |
| NZ (1) | NZ556004A (enExample) |
| SG (1) | SG160424A1 (enExample) |
| WO (1) | WO2006069262A2 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008527009A (ja) | 2005-01-19 | 2008-07-24 | バクシネート コーポレーション | 病原体関連分子パターンおよび抗原を含む組成物ならびに免疫応答を刺激するためのそれらの使用 |
| EP2476432B1 (en) | 2006-03-07 | 2015-08-19 | Vaxinnate Corporation | Compositions that include hemagglutinin, methods of making and methods of use thereof |
| EP2012829A4 (en) * | 2006-04-24 | 2010-04-21 | Protelix Inc | PROCESS FOR PRODUCING VIRAL VACCINE AND THERAPEUTIC PEPTIDE ANTIGENS |
| ES2520026T3 (es) * | 2006-09-18 | 2014-11-11 | The Board Of Trustees Of The University Of Arkansas | Composiciones y métodos para potenciar respuestas inmunitarias |
| EP1925318A1 (en) * | 2006-11-20 | 2008-05-28 | Paul-Ehrlich-Institut | Recombinant modified vaccinia virus Ankara (MVA)-based vaccine for the avian flu |
| US8778847B2 (en) * | 2007-06-13 | 2014-07-15 | The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | Immunogenic peptides of influenza virus |
| ES2539818T3 (es) | 2007-08-02 | 2015-07-06 | Biondvax Pharmaceuticals Ltd. | Vacunas contra la gripe multiepitópicas multiméricas |
| GB0720250D0 (en) | 2007-10-17 | 2007-11-28 | Univ Edinburgh | Immunogenic compositions containing escherichia coli h7 flagella and methods of use thereof |
| US8470771B2 (en) | 2007-11-14 | 2013-06-25 | Institute Of Microbiology, Chinese Academy Of Sciences | Method and medicament for inhibiting the infection of influenza virus |
| SG190562A1 (en) | 2008-04-18 | 2013-06-28 | Vaxinnate Corp | Deletion mutants of flagellin and methods of use |
| JP2012523379A (ja) | 2009-04-09 | 2012-10-04 | ザ ユニバーシティー オブ メルボルン | 免疫原性組成物およびその使用 |
| MX348663B (es) * | 2009-09-08 | 2017-05-26 | Inst Tecnologico Estudios Superiores Monterrey | Proceso de producción de una vacuna recombinante, dicha vacuna expresable en cepas de escherichia coli y su uso para combatir la influenza a h1ni1 brote 2009. |
| MX2012007916A (es) * | 2010-01-06 | 2012-11-06 | Vaxinnate Corp | Metodos y composiciones para proporcionar inmunidad protectora en los adultos mayores. |
| CN102811734B (zh) | 2010-01-21 | 2016-02-10 | 阿肯色大学评议会 | 增强免疫应答的疫苗载体和方法 |
| AU2011230491A1 (en) * | 2010-03-26 | 2012-10-18 | Emergent Product Development Gaithersburg Inc. | Ectodomains of influenza Matrix 2 protein, expression system, and uses thereof |
| GB201009273D0 (en) * | 2010-06-03 | 2010-07-21 | Glaxosmithkline Biolog Sa | Novel vaccine |
| JP2013537892A (ja) * | 2010-09-22 | 2013-10-07 | ザ ユニバーシティー オブ メルボルン | 新規な免疫賦活法 |
| WO2012114323A1 (en) | 2011-02-22 | 2012-08-30 | Biondvax Pharmaceuticals Ltd. | Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines |
| US8932598B2 (en) | 2012-08-28 | 2015-01-13 | Vaxinnate Corporation | Fusion proteins and methods of use |
| US9889189B2 (en) | 2012-11-05 | 2018-02-13 | Georgia State University Research Foundation | Universal influenza vaccine based on heterologous multiple M2E proteins |
| RU2571944C1 (ru) * | 2014-10-17 | 2015-12-27 | Общество с ограниченной ответственностью "НТфарма" | Противогриппозная вакцина широкого спектра действия против птичьего гриппа а на основе эктодомена белка м2 |
| BR112020012360A2 (pt) | 2017-12-21 | 2020-11-24 | Ena Therapeutics Pty Ltd | compostos otimizados |
| WO2020257870A1 (en) | 2019-06-26 | 2020-12-30 | Ena Therapeutics Pty Ltd | Novel molecules |
| WO2023028661A1 (en) * | 2021-09-02 | 2023-03-09 | Ena Respiratory Pty Ltd | Formulation |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7569225B2 (en) * | 2002-08-12 | 2009-08-04 | The Council Of The Queensland Institute Of Medical Research | Immunogenic lipopeptides comprising T-helper and B-cell epitopes |
| MXPA05009580A (es) * | 2003-03-07 | 2005-10-19 | Merck & Co Inc | Vacuna contra el virus de la influenza. |
-
2005
- 2005-12-21 JP JP2007547054A patent/JP2008524261A/ja active Pending
- 2005-12-21 EP EP05855253A patent/EP1831259A2/en not_active Withdrawn
- 2005-12-21 MX MX2007007586A patent/MX2007007586A/es not_active Application Discontinuation
- 2005-12-21 BR BRPI0519705-8A patent/BRPI0519705A2/pt not_active IP Right Cessation
- 2005-12-21 CA CA002593746A patent/CA2593746A1/en not_active Abandoned
- 2005-12-21 WO PCT/US2005/046662 patent/WO2006069262A2/en not_active Ceased
- 2005-12-21 SG SG201001924-8A patent/SG160424A1/en unknown
- 2005-12-21 NZ NZ556004A patent/NZ556004A/en not_active IP Right Cessation
- 2005-12-21 AU AU2005319141A patent/AU2005319141B8/en not_active Ceased
-
2010
- 2010-01-07 AU AU2010200048A patent/AU2010200048A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| SG160424A1 (en) | 2010-04-29 |
| AU2005319141B8 (en) | 2010-03-18 |
| JP2008524261A (ja) | 2008-07-10 |
| AU2005319141B2 (en) | 2010-02-18 |
| NZ556004A (en) | 2010-05-28 |
| AU2010200048A1 (en) | 2010-01-28 |
| AU2005319141A1 (en) | 2006-06-29 |
| CA2593746A1 (en) | 2006-06-29 |
| EP1831259A2 (en) | 2007-09-12 |
| WO2006069262A2 (en) | 2006-06-29 |
| MX2007007586A (es) | 2007-12-10 |
| WO2006069262A3 (en) | 2007-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0519705A2 (pt) | composiÇÕes, proteÍnas de fusço e mÉtodos de estimular uma resposta imune em um indivÍduo | |
| CY1123952T1 (el) | Απομονωση και καθαρισμος αντισωματων αντι-il-13 με την χρηση χρωματογραφιας χημικης συγγενειας πρωτεινης α | |
| HN2006016512A (es) | Anticuerpos anti-il-6, composiciones, metodos y usos | |
| DK1939281T4 (da) | Immortaliserede andecellelinjer til virusproduktion | |
| CY1117162T1 (el) | Μεθοδος κατασκευης αντισωματος fc-ετεροδιμερικων μοριων χρησιμοποιωντας αποτελεσματα ηλεκτροστατικης καθοδηγησης | |
| AR057614A1 (es) | Composiciones y metodos para producir moleculas de union con antigeno hibridas y usos de las mismas | |
| BRPI0512396A (pt) | polipeptìdeos biossintéticos utilizando aminoácidos codificados não naturalmente | |
| BR0212363A (pt) | Expressão hìbrida e em tandem de proteìnas de neisseria | |
| AR038568A1 (es) | Anticuerpos anti-a beta y su uso | |
| BRPI0508935A (pt) | agonistas de receptor seletivo y4 para intervenções terapêuticas | |
| EA201100070A1 (ru) | Туберкулезный белок rv2386c, композиции и их применения | |
| BRPI0515649B8 (pt) | Processo para preparação de composições de anticorpo monoclonal altamente concentradas | |
| NO20063026L (no) | Antistoffer | |
| AR070690A1 (es) | Metodos y composiciones que utilizan polipeptidos de fusion de klotho-fgf (factor de crecimiento de fibroblastos) | |
| WO2007047829A3 (en) | Novel heterodimeric proteins and uses thereof | |
| CR11282A (es) | Proteinas enlazadas al antigeno de celula de cepa mcdonough de felino humanas | |
| ATE529442T1 (de) | Verbesserte humane interferon-moleküle und ihre verwendungen | |
| IL187168A (en) | Proteins or polypeptides which comprise two identical nanobodies against von willebrand factor, methods for their preparation, pharmaceutical compositions comprising them and their uses | |
| MY206284A (en) | Anti-cd63 antibodies, conjugates, and uses thereof | |
| ATE539089T1 (de) | Cyclische rezeptor-assoziierte-proteine (rap)- peptide | |
| EP4374913A3 (en) | Novel human serum albumin mutant | |
| WO2010074575A3 (en) | Recombinant classical swine fever virus (csfv) comprising a modified e2 protein and methods for generating said recombinant csfv. | |
| EA201100071A1 (ru) | Новые композиции и способы | |
| BR112022026580A2 (pt) | Composições e métodos para induzir uma resposta imune contra coronavírus | |
| NO20062709L (no) | Stamceller som er egnet for transplantasjon, fremstilling derav og farmasoytiske preperater omfattende nevnte stamceller |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application fees: dismissal - article 86 of industrial property law |
Free format text: REFERENTE A 6A ANUIDADE. |
|
| B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012. |